| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 187,441 | 180,851 | 201,666 | 240,397 | | Cost of Revenue | 138,904 | 139,408 | 153,542 | 185,308 | | | Gross Profit | 48,537 | 41,443 | 48,124 | 55,089 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,671 | 29,753 | 30,719 | 30,270 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,866 | 11,690 | 17,405 | 24,819 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 286 | 259 | 318 | 1,980 | | Earnings Before Interest And Taxes | 18,152 | 11,949 | 17,723 | 26,799 | | Interest Expense | 141 | 172 | 482 | 444 | | Income Before Tax | 18,011 | 11,777 | 17,241 | 26,355 | | Income Tax Expense | 5,322 | 4,257 | 6,293 | 8,678 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,689 | 7,520 | 10,948 | 17,677 | | | Non-recurring Events | | Discontinued Operations | 335 |
-
| 23 | (32) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,024 | 7,520 | 10,971 | 17,645 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,024 | $7,520 | $10,971 | $17,645 |
|
0.51% Nasdaq 
Income Statement
